摘要
尿路上皮癌是泌尿生殖系肿瘤中排名第2位的恶性肿瘤,其中上尿路尿路上皮癌(UTUC)占比约5%,亚洲地区可能更多,且78%的UTUC在诊断时存在侵袭性,包括膀胱袖口状切除术在内的根治性肾输尿管切除术是目前公认的治疗UTUC的标准术式。近年来,得益于放疗技术的不断发展,术后辅助放疗也逐步用于UTUC的治疗,但其疗效目前是一个争议话题,本文就UTUC行根治术后辅助放疗的疗效问题作此综述,以期对临床工作起到指导和帮助作用。
Urothelial carcinoma(UC)is the second most commonly diagnosed genitourinary tumor,and upper tract urothelial carcinoma(UTUC)accounts for 5%of UC in USA.It may be more in Asia.Senventy-eight percent of UTUC may be invasive when diagnosed.The radical nephroureterectomy(RNU)with bladder cuff is the golden standard treatment.In recent years,as the development of radiotherapy,adjuvant radiotherapy(ART)after RNU has been used to treat UTUC patients,but its efficacy is still a controversy.We did this review focusing on ART’s efficacy after RNU to guide and help the clinical practice.
作者
杨昆霖
李晓颖
李学松
周利群
Yang Kunlin;Li Xiaoying;Li Xuesong;Zhou Liqun(Department of Urology,Peking University First Hospital,Institute of Urology,Peking University,National Urological Cancer Center,Beijing 100034,China;Department of Radiotherapy,Peking University First Hospital,Beijing 100034,China)
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
2020年第5期394-396,共3页
Chinese Journal of Urology
关键词
放射疗法
辅助放疗
肾输尿管全长切除术
上尿路尿路上皮癌
Radiotherapy
Adjuvant radiotherapy
Radical nephroureterectomy
Upper tract urothelial carcinoma
